Literature DB >> 15576910

Angiogenesis assays in the chick CAM.

Chris Storgard1, David Mikolon, Dwayne G Stupack.   

Abstract

The growth of new blood vessels from pre-existing vascular elements, or angiogenesis, involves coordinated signals to the adhesion, migration, and survival machinery within the target endothelial cell. Agents that interfere with any of these processes may therefore influence angiogenesis. Here, we describe the angiogenesis assay in the chick chorioallantoic membrane (CAM). The CAM is a useful tool to studying angiogenesis because 1) it is amenable to both intravascular and topical administration of study agents, 2) it is a relatively rapid assay, and 3) it can be adapted very easily to study angiogenesis-dependent processes, such as tumor growth. Importantly, the CAM provides a physiological setting that permits investigation of pro- and anti-angiogenic agent interactions in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15576910     DOI: 10.1385/1-59259-860-9:123

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  15 in total

1.  van der Waals force-induced loading of proangiogenic nanoparticles on microbubbles for enhanced neovascularization.

Authors:  Jinrong Chen; Min Kyung Lee; Ellen Qin; Sanjay Misra; Hyunjoon Kong
Journal:  Nanoscale       Date:  2015-10-28       Impact factor: 7.790

2.  Chemerin is secreted by the chicken oviduct, accumulates in egg albumen and could promote embryo development.

Authors:  Anthony Estienne; Adeline Brossaud; Christelle Ramé; Ophélie Bernardi; Maxime Reverchon; Christophe Rat; Joël Delaveau; Emilie Chambellon; Emmanuelle Helloin; Pascal Froment; Joëlle Dupont
Journal:  Sci Rep       Date:  2022-05-29       Impact factor: 4.996

Review 3.  FERM control of FAK function: implications for cancer therapy.

Authors:  Ssang-Taek Lim; David Mikolon; Dwayne G Stupack; David D Schlaepfer
Journal:  Cell Cycle       Date:  2008-05-29       Impact factor: 4.534

Review 4.  Microcomputed tomography characterization of neovascularization in bone tissue engineering applications.

Authors:  Simon Young; James D Kretlow; Charles Nguyen; Alex G Bashoura; L Scott Baggett; John A Jansen; Mark Wong; Antonios G Mikos
Journal:  Tissue Eng Part B Rev       Date:  2008-09       Impact factor: 6.389

5.  The growth factor Midkine antagonizes VEGF signaling in vitro and in vivo.

Authors:  Edward Htun van der Horst; Brendon T Frank; Lawrence Chinn; Angela Coxon; Shyun Li; Fanny Polesso; Anthony Slavin; Astrid Ruefli-Brasse; Holger Wesche
Journal:  Neoplasia       Date:  2008-04       Impact factor: 5.715

6.  The marine lipopeptide somocystinamide A triggers apoptosis via caspase 8.

Authors:  Wolf Wrasidlo; Ainhoa Mielgo; Vicente A Torres; Simone Barbero; Konstantin Stoletov; Takashi L Suyama; Richard L Klemke; William H Gerwick; Dennis A Carson; Dwayne G Stupack
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-11       Impact factor: 11.205

7.  TIMP-2 fusion protein with human serum albumin potentiates anti-angiogenesis-mediated inhibition of tumor growth by suppressing MMP-2 expression.

Authors:  Mi-Sook Lee; Jae-In Jung; Seung-Hae Kwon; Sang-Mok Lee; Kyoji Morita; Song Her
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

8.  Testosterone selectively increases primary follicles in ovarian cortex grafted onto embryonic chick membranes: relevance to polycystic ovaries.

Authors:  A I Qureshi; S S Nussey; G Bano; P Musonda; S A Whitehead; H D Mason
Journal:  Reproduction       Date:  2008-05-02       Impact factor: 3.906

9.  Thermosensitive Betulinic Acid-Loaded Magnetoliposomes: A Promising Antitumor Potential for Highly Aggressive Human Breast Adenocarcinoma Cells Under Hyperthermic Conditions.

Authors:  Claudia Geanina Farcas; Cristina Dehelean; Iulia Andreea Pinzaru; Marius Mioc; Vlad Socoliuc; Elena-Alina Moaca; Stefana Avram; Roxana Ghiulai; Dorina Coricovac; Ioana Pavel; Praveen Kumar Alla; Octavian Marius Cretu; Codruta Soica; Felicia Loghin
Journal:  Int J Nanomedicine       Date:  2020-10-23

10.  A dominant-negative FGF1 mutant (the R50E mutant) suppresses tumorigenesis and angiogenesis.

Authors:  Seiji Mori; Vu Tran; Kyoko Nishikawa; Teruya Kaneda; Yoshinosuke Hamada; Naomasa Kawaguchi; Masaaki Fujita; Jun Saegusa; Yoko K Takada; Nariaki Matsuura; Min Zhao; Yoshikazu Takada
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.